Search Results

Safety, Tolerability, and Pharmacokinetics of Mirvetuximab Soravtansine in Chinese Patients With Folate Receptor α-Positive Advanced Ovarian Cancer.

• Authors : Li Y; Chongqing University Cancer Hospital, Chongqing, China.; Yuan L

Subjects: Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/drug therapy ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/pathology ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/metabolism

• Source: Cancer medicine [Cancer Med] 2026 May; Vol. 15 (5), pp. e71704.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Angiotensin receptor blockers use and lung cancer risk in Chinese patients with chronic obstructive pulmonary disease: a population-based cohort study.

• Authors : Li, Wenhao¹ (AUTHOR); Yang, Qingqing² (AUTHOR); Chen, Yahong³ (AUTHOR)

• Source: Respiratory Research. 5/15/2025, Vol. 26 Issue 1, p1-10. 10p.

Record details

Effect of obesity and endocrine therapy on the prognosis of premenopausal women with HR+HER2-breast cancer: a multi-center retrospective study.

• Authors : Lian W; Department of Breast Surgery, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, 362000, Fujian, People's Republic of China. .; Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, 350000, Fujian, People's Republic of China. .

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/metabolism ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/pathology

• Source: Scientific reports [Sci Rep] 2026 May 18; Vol. 16 (1). Date of Electronic Publication: 2026 May 18.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Real-World Utility of Immunoglobulin G4 Subtype Phospholipase A2 Receptor Autoantibodies in Diagnosing Phospholipase A2 Receptor--Associated Membranous Nephropathy.

• Authors : Zhong, Yongzhong^1,2; Liu, Yunyun³; Chen, Dacheng¹

• Source: Archives of Pathology & Laboratory Medicine. May2026, Vol. 150 Issue 5, p365-373. 9p.

Record details

Silencing C-X-C motif chemokine receptor inhibited autophagy of hippocampal neurons in epileptic mice by upregulating TWIK-related K+ Channel 1.

• Authors : Chen, Hong¹ (AUTHOR); Wang, Wenzeng² (AUTHOR); Feng, Daqing¹ (AUTHOR)

• Source: CytoJournal. 2/28/2026, Vol. 23, p1-12. 12p.

Record details

Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular outcomes in older adults with type 2 diabetes mellitus: a target trial emulation study.

• Authors : Zeng W; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University Health Science Center, Peking University, No.38 Xueyuan Road, Beijing, 100191, China.; Wang T

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/diagnosis ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/mortality ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

• Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2025 May 06; Vol. 24 (1), pp. 194. Date of Electronic Publication: 2025 May 06.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840

Record details

Association of the angiotensin II type 1 receptor A1166C polymorphism with essential hypertension in the Chinese population: a meta-analysis with ethnic and geographic subgroup analyses.

• Authors : Gu J; Department of Endocrinology, The First Affiliated Hospital of Hebei North University, Zhangjiakou City, Hebei Province, China.; Shi L

Subjects: Essential Hypertension*/Essential Hypertension*/Essential Hypertension*/genetics ; Receptor, Angiotensin, Type 1*/Receptor, Angiotensin, Type 1*/Receptor, Angiotensin, Type 1*/genetics ; Polymorphism, Single Nucleotide*

• Source: Blood pressure [Blood Press] 2026 Dec; Vol. 35 (1), pp. 2676370. Date of Electronic Publication: 2026 Jun 01.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9301454 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Interaction between toll-like receptor 4 polymorphism and abdominal obesity on ovarian cancer risk in Chinese women.

• Authors : Zhu J; Department of Oncology, the Affiliated Jiangyin Hospital of Nantong University, Jiangyin city, 214400, Jiangsu Province, China.; Yang B

Subjects: Obesity, Abdominal*/Obesity, Abdominal*/Obesity, Abdominal*/genetics ; Obesity, Abdominal*/Obesity, Abdominal*/Obesity, Abdominal*/complications ; Obesity, Abdominal*/Obesity, Abdominal*/Obesity, Abdominal*/epidemiology

• Source: BMC women's health [BMC Womens Health] 2025 Sep 29; Vol. 25 (1), pp. 452. Date of Electronic Publication: 2025 Sep 29.Publisher: BioMed Central Country of Publication: England NLM ID: 101088690 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6874

Record details

A novel candidate tumor biomarker progestin and adipoQ receptor 3 regulates cell metastasis through transforming growth factor-β pathway in hepatocellular carcinoma.

• Authors : Liang, Xiaohui^1,2 (AUTHOR) ; Ding, Yan³ (AUTHOR); Liu, Wenna⁴ (AUTHOR)

• Source: CytoJournal. 12/10/2025, Vol. 22, p1-11. 11p.

Record details

Factors Associating with Bone-Only Metastasis in Chinese Breast Cancer Patients in the Absence of Anti-Human Epidermal Growth Factor Receptor 2-Targeted Therapy.

• Authors : Li Z; Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.; Chen L

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/pathology ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/therapy ; Erb-b2 Receptor Tyrosine Kinases*/Erb-b2 Receptor Tyrosine Kinases*/Erb-b2 Receptor Tyrosine Kinases*/antagonists & inhibitors

• Source: Oncology research and treatment [Oncol Res Treat] 2025; Vol. 48 (3), pp. 112-124. Date of Electronic Publication: 2024 Dec 16.Publisher: S. Karger Country of Publication: Switzerland NLM ID: 101627692 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details